PTX-3 and zinc as potential markers of disease severity during sickle cell painful crisis

Completed

• Conditions: sickle cell; 10018902; sickle cell crisis

• Registration Number: NL-OMON37308
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

* High performance liquid chromatography confirmed diagnosis of HbSS, HbSC, HbS*0- or HbS*+-thalassemia genotype in SCD patients.
* Written informed consent by the patient.
*18 years and older

Exclusion Criteria

1. Pregnancy
2. Active cancer
3. Chronic HIV infection
4. Recent vaso-occlusive crisis (< 3 months)
5. Chronic transfusion therapy
6. Recent blood transfusion (< 3 months)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>na</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>